Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 38: 904-908, 1992;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leary, N. O.
Right arrow Articles by Duggan, P. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leary, N. O.
Right arrow Articles by Duggan, P. F.

Clinical Chemistry, Vol 38, 904-908, Copyright © 1992 by American Association for Clinical Chemistry

Single stable reagent (Arsenazo III) for optically robust measurement of calcium in serum and plasma

NO Leary, A Pembroke and PF Duggan
Biochemistry Laboratory, Regional Hospital, Cork, Ireland.

We describe a method based on a single stable reagent for the determination of calcium in serum and plasma with use of Arsenazo III, 200 mumol/L in 50 mmol/L 1,4-piperazinediethanesulfonic acid (PIPES) buffer. The method showed significant positive interference in plasma at pH less than 6.6 because of the precipitation of fibrinogen, which was eliminated by increasing the pH to 6.8. The assay showed no interference from as much as 600 mumol of bilirubin and 12 g of hemoglobin per liter when applied in a simple monochromatic procedure at 660 nm. The standard curve for calcium was linear from 0 to 5.0 mmol/L. Addition of Intralipid at concentrations greater than 3 g/L demonstrated positive interference, which could be eliminated by using a 700-nm blanking wavelength. The procedure showed good agreement with all-method mean values from two external quality-control schemes.


The following articles in journals at HighWire Press have cited this article:


Home page
J. Biol. Chem.Home page
V. Kartsogiannis, N. A. Sims, J. M. W. Quinn, C. Ly, M. Cipetic, I. J. Poulton, E. C. Walker, H. Saleh, N. E. McGregor, M. E. Wallace, et al.
Osteoclast Inhibitory Lectin, an Immune Cell Product That Is Required for Normal Bone Physiology in Vivo
J. Biol. Chem., November 7, 2008; 283(45): 30850 - 30860.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Sugano, K. Yamauchi, K. Sugano, K. Kawasaki, M. Tozuka, T. Katsuyama, H. Soya, T. Tanaka, S. Imamura, and S. Nomoto
New Enzymatic Assay Using Phospholipase D to Measure Total Calcium in Serum
Clin. Chem., June 1, 2005; 51(6): 1021 - 1024.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Association for Clinical Chemistry.